Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 06/24 10:00:02 pm
7.18 USD   -4.77%
06/24 ARIAD PHARMACEU : Announces Webcast of Its Annual Stockholders Meeti..
06/17 ARIAD PHARMACEU : Announces Distribution Agreements for Iclusig in L..
06/17 ARIAD PHARMACEU : Completes Strategic Review and Announces Plans for..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
7.5(c) 7.23(c) 7.27(c) 7.54(c) 7.18(c) Last
3 782 788 4 861 671 3 181 910 3 379 454 7 073 607 Volume
-0.27% -3.60% +0.55% +3.71% -4.77% Change
More quotes
Financials ($)
Sales 2016 216 M
EBIT 2016 -95,7 M
Net income 2016 -107 M
Debt 2016 224 M
Yield 2016 -
Sales 2017 252 M
EBIT 2017 -67,0 M
Net income 2017 -84,4 M
Debt 2017 240 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 7,42x
EV / Sales2017 6,42x
Capitalization 1 375 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
Sector
Biotechnology & Medical Research
Calendar
07/21 | 04:00pmShareholder meeting
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
06/24 ARIAD PHARMACEUTICALS : Announces Webcast of Its Annual Stockholders Meeting
06/23 ARIAD PHARMACEUTICALS : Announces Long-Term Safety and Efficacy Data of Ponatini..
06/17 ARIAD PHARMACEUTICALS : Announces Distribution Agreements for Iclusig in Latin A..
06/17 ARIAD PHARMACEUTICALS : Completes Strategic Review and Announces Plans for Growt..
06/17 ARIAD PHARMACEUTICALS : Announces Distribution Agreements for Iclusig® in Latin ..
06/16 ARIAD PHARMACEUTICALS : to Host Analyst & Investor Day in New York City
06/16 ARIAD PHARMACEUTICALS : Presents Data from Mutational Profiling in Crizotinib-Re..
06/13 ARIAD PHARMACEUTICALS : Announces Long-Term Safety and Efficacy Data of Ponatini..
06/11 ARIAD PHARMACEUTICALS : Investigational Medicine Brigatinib Demonstrates 54 Perc..
06/09 ARIAD PHARMACEUTICALS : Announces Initiation of Phase 1/2 Clinical Trial of AP32..
More news
Sector news : Bio Therapeutic Drugs
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/20 Ariad Taking The Fast Track Into Lung Cancer Treatment
06/17 BIOTECH FORUM DAILY DIGEST : Relypsa Gets Some Love; Paratek Delivers; Merck's K..
06/17 ARIAD announces distribution agreements for Iclusig in Latin America and MENA
06/17 ARIAD Pharma readies rolling NDA submission for brigatinib for lung cancer
06/15 Bellicum Is The Driverless Car Of The Immunotherapy Space
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions